Aurobindo Pharma Limited Unclassified
FDA Approved Drugs

Aurobindo Pharma Limited Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 43
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
1128
View
Unclassified
43
View
Discontinued
121
View
OTC
67
View
RX
897
View
Company Overview

Company

Aurobindo Pharma Limited Unclassified

Country

India

Website

Visit Website

Email

info@aurobindo.com

Social Profiles

Company Snapshot

Aurobindo Pharma Limited Unclassified

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad - 500038 Andhra Pradesh

India

www.aurobindo.com/ info@aurobindo.com View on Map
FDA Approved Drug Records ( 43 records )
-
Unclassified Application: 22293

Drug Name

ABACAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

22293 / 1

Active Ingredient

ABACAVIR SULFATE

Application Number

22293

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22295

Drug Name

ABACAVIR SULFATE; LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

60MG; 30MG

Approval Date

-

22295 / 1

Active Ingredient

ABACAVIR SULFATE; LAMIVUDINE

Application Number

22295

Product Number

1

Dosage Form

-

Strength

60MG; 30MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213900

Drug Name

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

213900 / 2

Active Ingredient

CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

213900

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213900

Drug Name

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

213900 / 3

Active Ingredient

CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

213900

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213900

Drug Name

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

213900 / 4

Active Ingredient

CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

213900

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219473

Drug Name

CENOBAMATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

219473 / 2

Active Ingredient

CENOBAMATE

Application Number

219473

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219473

Drug Name

CENOBAMATE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

219473 / 3

Active Ingredient

CENOBAMATE

Application Number

219473

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219473

Drug Name

CENOBAMATE

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

219473 / 4

Active Ingredient

CENOBAMATE

Application Number

219473

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219473

Drug Name

CENOBAMATE

Product Number

5

Dosage Form

-

Strength

25MG

Approval Date

-

219473 / 5

Active Ingredient

CENOBAMATE

Application Number

219473

Product Number

5

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219473

Drug Name

CENOBAMATE

Product Number

6

Dosage Form

-

Strength

12.5MG

Approval Date

-

219473 / 6

Active Ingredient

CENOBAMATE

Application Number

219473

Product Number

6

Dosage Form

-

Strength

12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211489

Drug Name

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

-

211489 / 5

Active Ingredient

DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

211489

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208355

Drug Name

DOLUTEGRAVIR SODIUM

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

208355 / 1

Active Ingredient

DOLUTEGRAVIR SODIUM

Application Number

208355

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210678

Drug Name

DRONEDARONE

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

-

210678 / 1

Active Ingredient

DRONEDARONE

Application Number

210678

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212371

Drug Name

EMPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

212371 / 1

Active Ingredient

EMPAGLIFLOZIN

Application Number

212371

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212371

Drug Name

EMPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

212371 / 2

Active Ingredient

EMPAGLIFLOZIN

Application Number

212371

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212374

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG/850MG

Approval Date

-

212374 / 2

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

212374

Product Number

2

Dosage Form

-

Strength

5MG/850MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212374

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

5MG/500MG

Approval Date

-

212374 / 3

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

212374

Product Number

3

Dosage Form

-

Strength

5MG/500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216875

Drug Name

EMTRICITABINE; TENOFOVIR ALAFENAMIDE

Product Number

1

Dosage Form

-

Strength

200MG/25MG

Approval Date

-

216875 / 1

Active Ingredient

EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Application Number

216875

Product Number

1

Dosage Form

-

Strength

200MG/25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220313

Drug Name

GLYCEROL PHENYLBUTYRATE

Product Number

2

Dosage Form

-

Strength

1.1G/1ML

Approval Date

-

220313 / 2

Active Ingredient

GLYCEROL PHENYLBUTYRATE

Application Number

220313

Product Number

2

Dosage Form

-

Strength

1.1G/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220313

Drug Name

GLYCEROL PHENYLBUTYRATE

Product Number

3

Dosage Form

-

Strength

450ML

Approval Date

-

220313 / 3

Active Ingredient

GLYCEROL PHENYLBUTYRATE

Application Number

220313

Product Number

3

Dosage Form

-

Strength

450ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204505

Drug Name

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

300MG; 300MG; 200MG

Approval Date

-

204505 / 1

Active Ingredient

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE

Application Number

204505

Product Number

1

Dosage Form

-

Strength

300MG; 300MG; 200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21943

Drug Name

LAMIVUDINE; ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

150MG; 300MG; 600MG

Approval Date

-

21943 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ

Application Number

21943

Product Number

1

Dosage Form

-

Strength

150MG; 300MG; 600MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22296

Drug Name

LAMIVUDINE; ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

22296 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE

Application Number

22296

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21944

Drug Name

LAMIVUDINE; ZIDOVUDINE; ABACAVIR

Product Number

1

Dosage Form

-

Strength

150MG; 300MG; 300MG

Approval Date

-

21944 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE; ABACAVIR

Application Number

21944

Product Number

1

Dosage Form

-

Strength

150MG; 300MG; 300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90401

Drug Name

LAMOTRIGINE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

90401 / 1

Active Ingredient

LAMOTRIGINE

Application Number

90401

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90471

Drug Name

LOPINAVIR; RITONAVIR

Product Number

1

Dosage Form

-

Strength

100MG; 25MG

Approval Date

-

90471 / 1

Active Ingredient

LOPINAVIR; RITONAVIR

Application Number

90471

Product Number

1

Dosage Form

-

Strength

100MG; 25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90471

Drug Name

LOPINAVIR; RITONAVIR

Product Number

2

Dosage Form

-

Strength

200MG; 50MG

Approval Date

-

90471 / 2

Active Ingredient

LOPINAVIR; RITONAVIR

Application Number

90471

Product Number

2

Dosage Form

-

Strength

200MG; 50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219085

Drug Name

LUMATEPERONE

Product Number

1

Dosage Form

-

Strength

42MG

Approval Date

-

219085 / 1

Active Ingredient

LUMATEPERONE

Application Number

219085

Product Number

1

Dosage Form

-

Strength

42MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219085

Drug Name

LUMATEPERONE

Product Number

2

Dosage Form

-

Strength

14MG

Approval Date

-

219085 / 2

Active Ingredient

LUMATEPERONE

Application Number

219085

Product Number

2

Dosage Form

-

Strength

14MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219085

Drug Name

LUMATEPERONE

Product Number

3

Dosage Form

-

Strength

28MG

Approval Date

-

219085 / 3

Active Ingredient

LUMATEPERONE

Application Number

219085

Product Number

3

Dosage Form

-

Strength

28MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219085

Drug Name

LUMATEPERONE

Product Number

4

Dosage Form

-

Strength

10.5MG

Approval Date

-

219085 / 4

Active Ingredient

LUMATEPERONE

Application Number

219085

Product Number

4

Dosage Form

-

Strength

10.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219085

Drug Name

LUMATEPERONE

Product Number

5

Dosage Form

-

Strength

21MG

Approval Date

-

219085 / 5

Active Ingredient

LUMATEPERONE

Application Number

219085

Product Number

5

Dosage Form

-

Strength

21MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 209413

Drug Name

MIRABEGRON

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

209413 / 1

Active Ingredient

MIRABEGRON

Application Number

209413

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22299

Drug Name

NEVIRAPINE TABLETS FOR ORAL SUSPENSION

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

22299 / 1

Active Ingredient

NEVIRAPINE

Application Number

22299

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214782

Drug Name

PIMAVANSERIN

Product Number

1

Dosage Form

-

Strength

34MG

Approval Date

-

214782 / 1

Active Ingredient

PIMAVANSERIN

Application Number

214782

Product Number

1

Dosage Form

-

Strength

34MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214859

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

-

214859 / 2

Active Ingredient

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

214859

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214859

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

1000MG

Approval Date

-

214859 / 3

Active Ingredient

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

214859

Product Number

3

Dosage Form

-

Strength

1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218725

Drug Name

SOLRIAMFETOL

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

-

218725 / 2

Active Ingredient

SOLRIAMFETOL

Application Number

218725

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218725

Drug Name

SOLRIAMFETOL

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

218725 / 3

Active Ingredient

SOLRIAMFETOL

Application Number

218725

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219088

Drug Name

UBROGEPANT

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

219088 / 1

Active Ingredient

UBROGEPANT

Application Number

219088

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219088

Drug Name

UBROGEPANT

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

219088 / 2

Active Ingredient

UBROGEPANT

Application Number

219088

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218866

Drug Name

UPADACITINIB

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

-

218866 / 1

Active Ingredient

UPADACITINIB

Application Number

218866

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218866

Drug Name

UPADACITINIB

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

-

218866 / 2

Active Ingredient

UPADACITINIB

Application Number

218866

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    81 View
  • EDQM CEP
    208 View
  • KDMF
    0 View
  • Japan DMF
    53 View
  • Eudra GMP
    0 View
  • NDC Database
    869 View
  • FDA Approved Drugs Database
    1,128 View
Drug Status Breakdown
43 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABACAVIR SULFATE

Application Number

22293

Product Number

1

Active Ingredient

ABACAVIR SULFATE

Dosage Form

-

Strength

60MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit